Bronconex Acticap

Quốc gia: New Zealand

Ngôn ngữ: Tiếng Anh

Nguồn: Medsafe (Medicines Safety Authority)

Thành phần hoạt chất:

Mometasone furoate 400ug (anhydrous)

Sẵn có từ:

Organon (New Zealand) Limited

INN (Tên quốc tế):

Mometasone furoate 400 µg (anhydrous)

Liều dùng:

400 mcg/dose

Dạng dược phẩm:

Powder for inhalation

Thành phần:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Các đơn vị trong gói:

Inhaler, metered, DPI, (sample), 14 dose units

Lớp học:

Prescription

Loại thuốc theo toa:

Prescription

Sản xuất bởi:

MSD International GmbH (Singapore Branch)

Chỉ dẫn điều trị:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Tóm tắt sản phẩm:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Ngày ủy quyền:

2000-12-05